References
- Gould, K. Antibiotics: From Prehistory to the Present Day. J. Antimicrob. Chemother. 2016, 71, 572–575. DOI: https://doi.org/10.1093/jac/dkv484.
- Kathrin, I. M. History of Antibiotics Research. Curr. Top. Microbiol. Immunol. 2016, 398, 237–272.
- Williamson, N. R.; Fineran, P. C.; Leeper, F. J.; Salmond, G. P. C. The Biosynthesis and Regulation of Bacterial Prodiginines. Nat. Rev. Microbiol. 2006, 4, 887–899. DOI:https://doi.org/10.1038/nrmicre1531.
- You, Z. Y.; Zhang, S. P.; Liu, X. X.; Zhang, J.; Wang, Y. J.; Peng, Y. J.; Wu, W. J. Insights into the anti-Infective Properties of Prodiginines. Appl. Microbiol. Biotechnol. 2019, 103, 2873–2887. DOI: https://doi.org/10.1007/s00253-019-09641-1.
- Ji, S. B.; Sun, R. L.; Xu, K.; Man, Z. D.; Ji, J. H.; Pu, Y. Q.; Yin, L. H.; Zhang, J.; Pu, Y. P. Prodigiosin Induces Apoptosis and Inhibits Autophagy via the Extracellular Signal-Regulated Kinase Pathway in K562 Cells. Toxicol. In Vitro. 2019, 60, 107–115. DOI: https://doi.org/10.1016/j.tiv.2019.05.003.
- Wang, Z. Y.; Li, B.; Zhou, L.; Yu, S. B.; Su, Z. J.; Song, J. X.; Sun, Q.; Sha, Q.; Wang, X. M.; Jiang, W. Q.; et al. Prodigiosin Inhibits Wnt/β-Catenin Signaling and Exerts Anticancer Activity in Breast Cancer Cells. Proc. Natl. Acad. Sci. USA. 2016, 113, 13150–13155. DOI: https://doi.org/10.1073/pnas.1616336113.
- Danevčič, T.; Vezjak, M. B.; Zorec, M.; Stopar, D. Prodigiosin – A Multifaceted Escherichia coli Antimicrobial Agent. PLoS One. 2016, 11, e0162412. DOI: https://doi.org/10.1371/journal.pone.0162412.
- Suryawanshi, R. K.; Patil, C. D.; Borase, H. P.; Salunke, B. K.; Patil, S. V. Studies on Production and Biological Potential of Prodigiosin by Serratia marcescens. Appl. Biochem. Biotechnol. 2014, 173, 1209–1221. DOI: https://doi.org/10.1007/s12010-014-0921-3.
- Arivizhivendhan, K. V.; Mahesh, M.; Boopathy, R.; Swarnalatha, S.; Regina, M. R.; Sekaran, G. Antioxidant and Antimicrobial Activity of Bioactive Prodigiosin Produces from Serratia marcescens Using Agricultural Waste as a Substrate. J. Food Sci. Technol. 2018, 55, 2661–2670. DOI: https://doi.org/10.1007/s13197-018-3188-9.
- Darshan, N.; Manonmani, H. K. Prodigiosin Inhibits Motility and Activates Bacterial Cell Death Revealing Molecular Biomarkers of Programmed Cell Death. AMB Express. 2016, 6, 50. DOI:https://doi.org/10.1186/s13568-106-0222-z.
- Herráez, R.; Mur, A.; Merlos, A.; Vinas, M.; Vinuesa, T. Using Prodigiosin Against Some Gram-Positive and Gram-Negative Bacteria and Trypanosoma cruzi. J. Venom. Anim. Toxins Incl. Trop. Dis. 2019, 25, e20190001 DOI: https://doi.org/10.1590/1678-9199-JVATITD-2019-0001.
- Brown, E. D.; Wright, G. D. Antibacterial Drug Discovery in the Resistance era. Nature 2016, 529, 336–343. DOI: https://doi.org/10.1038/nature17042.
- Kavanagh, K. T. Control of MSSA and MRSA in the United States: Protocols, Policies, Risk Adjustment and Excuses. Antimicrob. Resist. Infect. Control. 2019, 8, 103. DOI: https://doi.org/10.1186/s13756-019-0550-2.
- Vestergaard, M.; Frees, D.; Ingmer, H. Antibiotic Resistance and the MRSA Problem. Microbiol. Spectr. 2019, 7, 1128. DOI: https://doi.org/10.1128/microbiolspec.gpp3-0057-2018.
- Cong, Y. G.; Yang, S. J.; Rao, X. C. Vancomycin Resistant Staphylococcus aureus Infections: A Review of Case Updating and Clinical Features. J. Adv. Res. 2020, 21, 169–176. DOI: https://doi.org/10.1016/j.jare.2019.10.005.
- Bal, A. M.; David, M. Z.; Garau, J.; Gottlieb, T.; Mazzei, T.; Scaglione, F.; Tattevin, P.; Gould, I. M. Future Trends in the Treatment of Methicillin-Resistant Staphylococcus aureus (MRSA) Infection: An In-Depth Review of Newer Antibiotics Active Against an Enduring Pathogen. J. Glob. Antimicrob. Resist. 2017, 10, 295–303. DOI: https://doi.org/10.1016/j.jgar.2017.05019.
- Assis, L. M.; Nedeljković, M.; Dessen, A. New Strategies for Targeting and Treatment of Multi-Drug Resistant Staphylococcus aureus. Drug. Resist. Updates. 2017, 31, 1–14. DOI: https://doi.org/10.1016/j.drup.2017.03.001.
- Cunha, R. D.; Fonseca, L. P.; Calado, C. Antibiotic Discovery: Where Have we Come from, Where Do we Go? Antibiotics. 2019, 8, 45. DOI: https://doi.org/10.3390/antibiotics8020045.
- Kimyon, Ö.; Theerthankar, D.; Ibugo, A. I.; Kutty, S. K.; Ho, K. K.; Jan, T.; Naresh, K.; Mike, M. Serratia Secondary Metabolite Prodigiosin Inhibits Pseudomonas aeruginosa Biofilm Development by Producing Reactive Oxygen Species That Damage Biological Molecules. Front. Microbiol. 2016, 7, 972. DOI: https://doi.org/10.3389/fmicb.2016.00972.
- Park, G.; Tomlinson, J. T.; Melvin, M. S.; Wright, M. W.; Day, C. S.; Manderville, R. A. Zinc and Copper Complexes of Prodigiosin: Implications for Copper-Mediated Double-Strand DNA Cleavage. Org. Lett. 2003, 5, 113–116. DOI:https://doi.org/10.1021/o1027165s.
- Vaidya, M.; McBain, A. J.; Banks, C. E.; Whitehead, K. A. Single and Combined Antimicrobial Efficacies for Nine Metal Ion Solutions against Klebsiella pneumoniae, Acinetobacter baumannii and Enterococcus faecium. Int. Biodeter. Biodegr. 2019, 141, 39–43. DOI: https://doi.org/10.1016/j.ibiod.2018.06.017.
- Möhler, J. S.; Kolmar, T.; Synnatschke, K.; Hergert, M.; Wilson, L. A.; Ramu, S.; Elliott, A. G.; Blaskovich, M. A. T.; Sidjabat, H. E.; Paterson, D. L.; et al. Enhancement of Antibiotic-Activity Through Complexation with Metal Ions – Combined ITC, NMR, Enzymatic and Biological Studies. J. Inorg. Biochem. 2017, 167, 134–141. DOI: https://doi.org/10.1016/j.jinorgbio.2016.11.028.
- Vaidya, M. Y.; McBain, A. J.; Butler, J. A.; Banks, C. E.; Whitehead, K. A. Antimicrobial Efficacy and Synergy of Metal Ions against Enterococcus faecium, Klebsiella pneumoniae and Acinetobacter baumannii in Planktonic and Biofilm Phenotypes. Sci. Rep. 2017, 7, 1–9. DOI: https://doi.org/10.1038/s41598-017-05976-9.
- Liu, X. X.; Wang, Y. J.; Sun, S. Q.; Zhu, C. J.; Xu, W.; Park, Y. D.; Zhou, H. M. Mutant Breeding of Serratia marcescens Strain for Enhancing Prodigiosin Production and Application to Textiles. Prep. Biochem. Biotechnol. 2013, 43, 271–284. DOI: https://doi.org/10.1080/108260-68.2012.721850.
- Sun, S. Q.; Wang, Y. J.; Xu, W.; Zhu, C. J.; Liu, X. X. Optimizing Ultrasound-Assisted Extraction of Prodigiosin by Response Surface Methodology. Prep. Biochem. Biotechnol. 2015, 45, 101–108. DOI: https://doi.org/10.1080/10826068.2013.877029.
- Yarlagadda, V.; Akkapeddi, P.; Manjunath, G. B.; Haldar, J. Membrane Active Vancomycin Analogues: A Strategy to Combat Bacterial Resistance. J. Med. Chem. 2014, 57, 4558–4568. DOI: https://doi.org/10.1021/jm500270w.
- Davey, H. M.; Hexley, P. Red but not Dead? Membranes of Stressed Saccharomyces cerevisiae Are Permeable to Propidium Iodide. Environ. Microbiol. 2011, 13, 163–171. DOOI: DOI: https://doi.org/10.1111/j.1462-2920.2010.02317.x.
- Wang, Y.; Hammes, F.; De Roy, K.; Verstraete, W.; Boon, N. Boon, N. Past, Present and Future Applications of Flow Cytometry in Aquatic Microbiology. Trends. Biotechnol. 2010, 28, 416–424. DOI: https://doi.org/10.1016/j.tibtech.2010.04.006.
- Suryawanshi, R. K.; Patil, C. D.; Koli, S. H.; Hallsworth, J. E.; Patil, S. V. Antimicrobial Activity of Prodigiosin is Attributable to Plasma-Membrane Damage. Nat. Prod. Res. 2017, 31, 572–577. DOI: https://doi.org/10.1080/14786419.2016.1195380.
- Suryawanshi, R. L.; Patil, C. D.; Borase, H. P.; Narkhede, C. P.; Stevenson, A.; Hallsworth, J. E.; Patil, S. V. Towards an Understanding of Bacterial Metabolites Prodigiosin and Violacein and Their Potential for use in Commercial Sunscreens. Int. J. Cosmet. Sci. 2015, 37, 98–107. DOI: https://doi.org/10.1111/ics.12175.
- Ji, K.; Jeong, T. H.; Kim, Y. T. Anti-MRSA Properties of Prodigiosin from Serratia Sp. PDGS 120915. J. Life. Sci. 2015, 25, 29–36. DOI: https://doi.org/10.5352/JLS.2015.25.1.29.
- Lapenda, J. C.; Silva, P. A.; Vicalvi, M. C.; Sena, K. X. F. R.; Nascimento, S. C. Antimicrobial Activity of Prodigiosin Isolated from Serratia marcescens UFPEDA 398. World. J. Microbiol. Biotechnol. 2015, 31, 399–406. DOI: https://doi.org/10.1007/s11274-014-1793-y.
- Lee, J. S.; Kim, Y. S.; Park, S.; Kim, J.; Kang, S. J.; Lee, M. H.; Ryu, S. S.; Choi, J. M.; Oh, T. K.; Yoon, J. H. Exceptional Production of Both Prodigiosin and Cycloprodigiosin as Major Metabolic Constituents by a Novel Marine bacterium, Zooshikella rubidus S1-1. Appl. Environ. Microbiol. 2011, 77, 4967–4973. DOI: https://doi.org/10.1128/AEM.01986-10.
- Anzai, T.; Matsumura, Y. Topological Analysis of TMEM180, A Newly Identified Membrane Protein That is Highly Expressed in Colorectal Cancer Cells. Biochem. Biophys. Res. Commun. 2019, 520, 566–572. DOI: https://doi.org/10.1016/j.bbrc.2019.10.0707.
- Danevčič, T.; Vezjak, M. B.; Tabor, M.; Zorec, M.; Stopar, D. Prodigiosin Induces Autolysins in Actively Grown Bacillus subtilis Cells. Front. Microbiol. 2016, 7, 27. DOI: https://doi.org/10.3389/fmicb.2016.00027.
- Bessa, L. J.; Ferreira, M.; Gameiro, P. Evaluation of Membrane Fluidity of Multidrug-Resistant Isolates of Escherichia coli and Staphylococcus aureus in Presence and Absence of Antibiotics. J. Photochem. Photobiol. B. 2018, 181, 150–156. DOI: https://doi.org/10.1016/j.jphotobiol.2